- Tytuł:
- Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
- Autorzy:
- Źródło:
- British journal of cancer [Br J Cancer] 2014 Nov 25; Vol. 111 (11), pp. 2051-7. Date of Electronic Publication: 2014 Sep 30.
- Typ publikacji:
- Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Bevacizumab ; Breast Neoplasms/chemistry ; Breast Neoplasms/mortality ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Receptor, ErbB-2/analysis ; Risk Factors
Czasopismo naukowe